(D09) Carcinoma in situ of other and unspecified sites

More details coming soon

Icon
122 821 in individuals diagnosis carcinoma in situ of other and unspecified sites confirmed
Icon
1 183 deaths with diagnosis carcinoma in situ of other and unspecified sites
Icon
1% mortality rate associated with the disease carcinoma in situ of other and unspecified sites

Diagnosis carcinoma in situ of other and unspecified sites is diagnosed Men are 26.73% more likely than Women

77 824

Men receive the diagnosis carcinoma in situ of other and unspecified sites

1 183 (1.5 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
44 997

Women receive the diagnosis carcinoma in situ of other and unspecified sites

0 (less than 0.1%)

Died from this diagnosis.

Risk Group for the Disease carcinoma in situ of other and unspecified sites - Men aged 60-64 and Women aged 65-69

Icon
In Men diagnosis is most often set at age 15-19, 25-94
Icon
Less common in men the disease occurs at Age 0-14, 20-24, 95+Less common in women the disease occurs at Age 0-19, 95+
Icon
In Women diagnosis is most often set at age 20-94

Disease Features carcinoma in situ of other and unspecified sites

Icon
Absence or low individual and public risk
Icon

Carcinoma in situ of other and unspecified sites - what does this mean

Carcinoma in situ of other and unspecified sites is a type of pre-cancerous lesion that occurs when abnormal cells grow in the innermost layer of the tissue of an organ or other body part. it is a localized form of cancer that has not spread to other parts of the body and is usually found early on in the course of the disease.

What happens during the disease - carcinoma in situ of other and unspecified sites

Carcinoma in situ of other and unspecified sites is a type of cancer that begins in the cells of the epithelium, which is the tissue that lines the organs and other parts of the body. it is caused by a mutation in the dna of these cells that causes them to grow and divide uncontrollably. this abnormal growth can spread to nearby tissue and organs, and if left untreated, can eventually lead to the development of a more aggressive form of cancer.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Physical exam
  • Imaging tests such as X-ray, CT scan, MRI, or ultrasound
  • Biopsy
  • Endoscopy
  • Blood tests
  • Urine tests
  • Tissue sample analysis

Treatment and Medical Assistance

Main goal: Treat Carcinoma in situ of other and unspecified sites
  • Surgery to remove the affected tissue
  • Radiation therapy to kill cancer cells
  • Photodynamic therapy to destroy cancer cells
  • Cryotherapy to freeze and destroy cancer cells
  • Chemotherapy to kill cancer cells
  • Immunotherapy to stimulate the body's immune system to fight cancer cells
  • Targeted therapy to block the growth and spread of cancer cells
  • Hormone therapy to reduce the growth of cancer cells
Icon
10 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Carcinoma in situ of other and unspecified sites - Prevention

Carcinoma in situ of other and unspecified sites can be prevented by avoiding risk factors such as smoking, sun exposure, and unhealthy diets, as well as by getting regular screenings and check-ups. additionally, early detection and prompt treatment of any existing precancerous lesions can help to reduce the risk of developing this type of cancer.

Specified forms of the disease

(D09.0) Carcinoma in situ: Bladder
(D09.1) Carcinoma in situ: Other and unspecified urinary organs
(D09.2) Carcinoma in situ: Eye
(D09.3) Carcinoma in situ: Thyroid and other endocrine glands
(D09.7) Carcinoma in situ of other specified sites
(D09.9) Carcinoma in situ, unspecified